PMC:7417114 / 683-835 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T5","span":{"begin":14,"end":21},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":" patients and testing in clinical trials. Here, we characterize more than 30 approved kinase inhibitors in terms of their antiviral potential, due to th"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3","span":{"begin":93,"end":103},"obj":"Chemical"},{"id":"T4","span":{"begin":122,"end":131},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":" patients and testing in clinical trials. Here, we characterize more than 30 approved kinase inhibitors in terms of their antiviral potential, due to th"}

{"project":"LitCovid-PubTator","denotations":[{"id":"12","span":{"begin":1,"end":9},"obj":"Species"}],"attributes":[{"id":"A12","pred":"tao:has_database_id","subj":"12","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" patients and testing in clinical trials. Here, we characterize more than 30 approved kinase inhibitors in terms of their antiviral potential, due to th"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T3","span":{"begin":86,"end":103},"obj":"http://purl.obolibrary.org/obo/GO_0033673"}],"text":" patients and testing in clinical trials. Here, we characterize more than 30 approved kinase inhibitors in terms of their antiviral potential, due to th"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T12","span":{"begin":93,"end":103},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T1117","span":{"begin":93,"end":103},"obj":"CHEBI:35222;CHEBI:35222"}],"text":" patients and testing in clinical trials. Here, we characterize more than 30 approved kinase inhibitors in terms of their antiviral potential, due to th"}